Schizophrenia, Published online: 31 October 2026; doi:10.1038/s41537-026-00826-y Neuroimaging has transformed the study of psychosis spectrum disorders (PSD), yielding major advances in our understanding of disease biology across molecular, circuit, and systems levels. Positron emission tomography established robust evidence for striatal dopamine dysfunction; magnetic resonance spectroscopy identified glutamatergic abnormalities, particularly early in illness; task-based functional MRI revealed impaired fronto-parietal recruitment during cognitive operations such as working memory; and resting-state fMRI uncovered widespread alterations in thalamo-cortical organization. Yet despite these ach
Alan Anticevic, Kun Yang. Can neuroimaging unlock precision therapeutics in psychosis spectrum disorders?. // Schizophrenia. – 2026. – DOI: 10.1038/s41537-026-00826-y. – URL: https://www.nature.com/articles/s41537-026-00826-y
Alan Anticevic & Kun Yang (2026). Can neuroimaging unlock precision therapeutics in psychosis spectrum disorders?. Schizophrenia. https://doi.org/10.1038/s41537-026-00826-y
Alan Anticevic and Kun Yang. “Can neuroimaging unlock precision therapeutics in psychosis spectrum disorders?.” Schizophrenia, 2026. doi:10.1038/s41537-026-00826-y.
@article{Anticevic2026,
title = {Can neuroimaging unlock precision therapeutics in psychosis spectrum disorders?},
author = {Anticevic, Alan and Yang, Kun},
journal = {Schizophrenia},
year = {2026},
doi = {10.1038/s41537-026-00826-y},
url = {https://www.nature.com/articles/s41537-026-00826-y}
}
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05030-x Comment on: ‘Association of accelerometer-monitored physical activity with incident cataract: epidemiological and genetic evidence’
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05032-9 NAION during incretin-based therapy: an optic nerve head still adapted to hypertension
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05016-9 Comparing refractive errors in CACNA1F and CABP4 -associated disease in a UK cohort
Eye, Published online: 19 November 2026; doi:10.1038/s41433-026-05018-7 Comment on: ‘Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease’